Functional capacity, health impact, and risk of sarcopenia in individuals with chronic obstructive pulmonary disease.
This study aimed to verify the functional capacity of individuals with chronic obstructive pulmonary disease (COPD) and its associated factors. This study is a cross-sectional, observational study with quantitative data analysis. It was performed with patients previously diagnosed with any degree o...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade Estadual de Maringá
2025-07-01
|
| Series: | Acta Scientiarum. Health Sciences |
| Subjects: | |
| Online Access: | https://periodicos.uem.br/ojs/index.php/ActaSciHealthSci/article/view/70249 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849429203204702208 |
|---|---|
| author | Janine Bosi Tonel Maitê Mendes Pellenz Maria Elaine Trevisan Ariovaldo Leal Fagundes Luciane Flores Jacobi |
| author_facet | Janine Bosi Tonel Maitê Mendes Pellenz Maria Elaine Trevisan Ariovaldo Leal Fagundes Luciane Flores Jacobi |
| author_sort | Janine Bosi Tonel |
| collection | DOAJ |
| description |
This study aimed to verify the functional capacity of individuals with chronic obstructive pulmonary disease (COPD) and its associated factors. This study is a cross-sectional, observational study with quantitative data analysis. It was performed with patients previously diagnosed with any degree of COPD: I (mild), II (moderate), III (severe), and IV (very severe). Functional capacity was assessed using the six-minute step test (6MST), the risk for sarcopenia was identified using the SARC-F + CC questionnaire, and the clinical impact of COPD was quantified using the COPD Assessment Test (CAT) questionnaire. Moreover, primary data were collected from the patients to identify associated factors. The results of the 37 patients evaluated (59.5% female; 81.1% elderly), 30 (81.1%) had reduced functional capacity. Out of these, 53.3% were at risk for sarcopenia and 93.3 % were somehow clinically impacted by COPD. Their impact was classified into mild to moderate (53.3%) and severe and very severe (40%). Furthermore, most patients (60%) had a recent diagnosis and almost all of them (96.7%) were smokers or former smokers. In conclusion, most patients had reduced functional capacity which was significantly associated with dyspnea and risk of sarcopenia.
|
| format | Article |
| id | doaj-art-27ad4e078eb84edd85489dfcd1b9d959 |
| institution | Kabale University |
| issn | 1679-9291 1807-8648 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Universidade Estadual de Maringá |
| record_format | Article |
| series | Acta Scientiarum. Health Sciences |
| spelling | doaj-art-27ad4e078eb84edd85489dfcd1b9d9592025-08-20T03:28:26ZengUniversidade Estadual de MaringáActa Scientiarum. Health Sciences1679-92911807-86482025-07-0147110.4025/actascihealthsci.v47i1.70249Functional capacity, health impact, and risk of sarcopenia in individuals with chronic obstructive pulmonary disease.Janine Bosi Tonel0Maitê Mendes Pellenz1Maria Elaine Trevisan2Ariovaldo Leal Fagundes3Luciane Flores Jacobi4Hospital Universitário de Santa MariaUniversidade Federal de Santa MariaUniversidade Federal de Santa MariaHospital Universitário de Santa MariaUniversidade Federal de Santa Maria This study aimed to verify the functional capacity of individuals with chronic obstructive pulmonary disease (COPD) and its associated factors. This study is a cross-sectional, observational study with quantitative data analysis. It was performed with patients previously diagnosed with any degree of COPD: I (mild), II (moderate), III (severe), and IV (very severe). Functional capacity was assessed using the six-minute step test (6MST), the risk for sarcopenia was identified using the SARC-F + CC questionnaire, and the clinical impact of COPD was quantified using the COPD Assessment Test (CAT) questionnaire. Moreover, primary data were collected from the patients to identify associated factors. The results of the 37 patients evaluated (59.5% female; 81.1% elderly), 30 (81.1%) had reduced functional capacity. Out of these, 53.3% were at risk for sarcopenia and 93.3 % were somehow clinically impacted by COPD. Their impact was classified into mild to moderate (53.3%) and severe and very severe (40%). Furthermore, most patients (60%) had a recent diagnosis and almost all of them (96.7%) were smokers or former smokers. In conclusion, most patients had reduced functional capacity which was significantly associated with dyspnea and risk of sarcopenia. https://periodicos.uem.br/ojs/index.php/ActaSciHealthSci/article/view/70249Chronic disease; exercise; dyspnea; respiratory system. |
| spellingShingle | Janine Bosi Tonel Maitê Mendes Pellenz Maria Elaine Trevisan Ariovaldo Leal Fagundes Luciane Flores Jacobi Functional capacity, health impact, and risk of sarcopenia in individuals with chronic obstructive pulmonary disease. Acta Scientiarum. Health Sciences Chronic disease; exercise; dyspnea; respiratory system. |
| title | Functional capacity, health impact, and risk of sarcopenia in individuals with chronic obstructive pulmonary disease. |
| title_full | Functional capacity, health impact, and risk of sarcopenia in individuals with chronic obstructive pulmonary disease. |
| title_fullStr | Functional capacity, health impact, and risk of sarcopenia in individuals with chronic obstructive pulmonary disease. |
| title_full_unstemmed | Functional capacity, health impact, and risk of sarcopenia in individuals with chronic obstructive pulmonary disease. |
| title_short | Functional capacity, health impact, and risk of sarcopenia in individuals with chronic obstructive pulmonary disease. |
| title_sort | functional capacity health impact and risk of sarcopenia in individuals with chronic obstructive pulmonary disease |
| topic | Chronic disease; exercise; dyspnea; respiratory system. |
| url | https://periodicos.uem.br/ojs/index.php/ActaSciHealthSci/article/view/70249 |
| work_keys_str_mv | AT janinebositonel functionalcapacityhealthimpactandriskofsarcopeniainindividualswithchronicobstructivepulmonarydisease AT maitemendespellenz functionalcapacityhealthimpactandriskofsarcopeniainindividualswithchronicobstructivepulmonarydisease AT mariaelainetrevisan functionalcapacityhealthimpactandriskofsarcopeniainindividualswithchronicobstructivepulmonarydisease AT ariovaldolealfagundes functionalcapacityhealthimpactandriskofsarcopeniainindividualswithchronicobstructivepulmonarydisease AT lucianefloresjacobi functionalcapacityhealthimpactandriskofsarcopeniainindividualswithchronicobstructivepulmonarydisease |